Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Irene Robinson

  • Home
  • Author: Irene Robinson

Slovakia’s national COVID-19 testing program was only a temporary solution

Following Slovakia’s national testing program from 31 October – 1 November, where two-thirds of the population were tested and the number of new daily cases dropped substantially, Slovakia was applauded for its efforts and held up as a possible solution to other European countries, says GlobalData, a leading data and analytics company. Katie Wrenn, Pharma Analyst at GlobalData, comments: “The recent weeks have seen a slight rise in new cases, and though this increase is minimal, if cases continue […]
Read more

The US has the largest number of late-stage COVID-19 vaccines in development

With Pfizer/BioNTech’s COVID-19 vaccine becoming the first mRNA vaccine in the world to receive emergency use approval by the UK’s Medicines & Healthcare Products Regulatory Agency (MHRA), the race is on for other bio/pharma companies with COVID-19 candidates to seek out authorization from regulators within the coming weeks, says GlobalData, a leading data and analytics company. Sharon Cartic at GlobalData comments: “The US has the largest number of COVID-19 vaccines in late-stage clinical development among the top pipeline geographies, with the EU following closely behind. The US currently has a total of 12 COVID-19 vaccines in Phases II and III, […]
Read more

Immune checkpoint inhibitors will represent 47% of the 5EU gastric and gastroesophageal market by 2029

The lack of approved immune checkpoint inhibitors (ICI) in the gastric and gastroesophageal adenocarcinoma (G/GEJAC) market in the *5EU is expected to significantly enhance the revenue of Opdivo and Keytruda following their upcoming label expansions. In fact, GlobalData’s latest report, ‘Gastric and Gastroesophageal Junction Adenocarcinoma Global Drug Forecast and Market Analysis to 2029’, notes that these […]
Read more

Nigeria to spearhead Africa refinery capacity additions by 2024

Nigeria is expected to drive the refinery capacity growth in Africa by 2024, contributing around 71% of the region’s total growth. Nigeria is likely to add 1.5 million barrels per day (mmbd) of refinery capacity by 2024, says GlobalData, a leading data and analytics company. GlobalData’s report, ‘Refining Industry Outlook in Africa to 2024’, reveals […]
Read more

Galapagos Phase IIA PINTA IPF topline study results are cause for cautious optimism

Galapagos recently reported positive topline results from its Phase IIA PINTA clinical trial investigating the use of 100 mg GLPG1205 for the treatment of idiopathic pulmonary fibrosis (IPF). Although the trial had a promising result in a disease with high unmet clinical need, the real test for the drug will come in the form of larger trials and subsequent statistical evaluation, according to GlobalData a leading data […]
Read more

An Estimated 60% of All Asthma Cases Go Undiagnosed in the UK

Currently in the UK, there are over nine million lifetime diagnosed prevalent cases of asthma and approximately 13 million undiagnosed asthma patients, says GlobalData, a leading data and analytics company. Bahram Hassanpourfard, Epidemiologist Analyst at GlobalData, comments: “The testing limitations of asthma in primary care services likely result in a high number of undiagnosed patients. NHS […]
Read more

Janssen’s PP6M set to be promising treatment to increase compliance rates in schizophrenia

Following the news that Janssen has submitted a Marketing Authorisation Extension to the European Medicines Agency (EMA) for its product paliperidone palmitate 6-Monthly (PP6M) for the treatment of schizophrenia in adults; Alessio Brunello, Managing Pharma Analyst at GlobalData, a leading data and analytics company, offers his view: “Antipsychotic medication are the most prescribed in schizophrenia, […]
Read more

Canada sets out COVID-19 plans to vaccinate a majority by September 2021

Following Prime Minister Justin Trudeau’s announcement of Canada’s vaccination schedules; James Spencer, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view: “With the recent announcement of several potential COVID-19 vaccines one after another, countries around the world have been scrambling to put together their vaccine plans. “Trudeau stated that he expects […]
Read more

Bladder cancer therapeutics market projected to exceed $5.5bn by 2028

The bladder cancer therapeutics market was valued at $670m in 2018 across the seven major markets (7MM*) and is expected to grow exponentially at a compound annual growth rate (CAGR) of 23.6% – accruing slightly less than $5.6bn in 2028, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Bladder Cancer Opportunity […]
Read more
1 2 3 4 5 … 15